Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
1993-12-16
pubmed:abstractText
The beta-lactamases obtained from culture supernatants and cell extracts of 26 clinical strains and 5 reference strains of Nocardia farcinica were partially characterized. The enzymes exhibited two patterns on isoelectric focusing (IEF). beta-Lactamases from the majority of the 31 strains (87%) including the 5 reference strains exhibited two major bands with pIs of 4.56 and 4.49. The remaining strains had two similar major bands but with slightly higher pIs. Culture supernatants and cell extracts exhibited identical patterns. The two sets of enzymes were functionally indistinguishable by substrate and inhibitor profiles and lack of inducibility. By disk testing, ampicillin, amoxicillin, ticarcillin, amoxicillin-clavulanic acid, and imipenem were highly synergistic with cefotaxime. The enzymes were primarily penicillinases and hydrolyzed cephalosporins at rates of < or = 12% of those for penicillins. N. farcinica beta-lactamases were susceptible to inhibition by clavulanic acid and BRL 42715, exhibiting 50% inhibitory concentrations of 0.025 to 0.045 micrograms/ml (0.12 to 0.22 microM) and 0.05 to 0.1 micrograms/ml (0.31 to 0.63 microM), respectively, less susceptible to tazobactam, and least susceptible to sulbactam, cloxacillin, and imipenem. The beta-lactamases of N. farcinica are believed to mediate penicillin resistance and may play a secondary role in extended-spectrum cephalosporin resistance. The close similarity among N. farcinica beta-lactamases and their distinct differences from beta-lactamases of other Nocardia species support the taxonomic identity of this species.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8239595-1952834, http://linkedlifedata.com/resource/pubmed/commentcorrection/8239595-2280003, http://linkedlifedata.com/resource/pubmed/commentcorrection/8239595-2514622, http://linkedlifedata.com/resource/pubmed/commentcorrection/8239595-2658780, http://linkedlifedata.com/resource/pubmed/commentcorrection/8239595-2679367, http://linkedlifedata.com/resource/pubmed/commentcorrection/8239595-2817854, http://linkedlifedata.com/resource/pubmed/commentcorrection/8239595-3072921, http://linkedlifedata.com/resource/pubmed/commentcorrection/8239595-311614, http://linkedlifedata.com/resource/pubmed/commentcorrection/8239595-3500241, http://linkedlifedata.com/resource/pubmed/commentcorrection/8239595-3501699, http://linkedlifedata.com/resource/pubmed/commentcorrection/8239595-3843705, http://linkedlifedata.com/resource/pubmed/commentcorrection/8239595-3873215, http://linkedlifedata.com/resource/pubmed/commentcorrection/8239595-3873900, http://linkedlifedata.com/resource/pubmed/commentcorrection/8239595-3882654, http://linkedlifedata.com/resource/pubmed/commentcorrection/8239595-5325707, http://linkedlifedata.com/resource/pubmed/commentcorrection/8239595-6300016, http://linkedlifedata.com/resource/pubmed/commentcorrection/8239595-6351733, http://linkedlifedata.com/resource/pubmed/commentcorrection/8239595-6808912, http://linkedlifedata.com/resource/pubmed/commentcorrection/8239595-6830207, http://linkedlifedata.com/resource/pubmed/commentcorrection/8239595-6968541, http://linkedlifedata.com/resource/pubmed/commentcorrection/8239595-879738, http://linkedlifedata.com/resource/pubmed/commentcorrection/8239595-950322
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0066-4804
pubmed:author
pubmed:issnType
Print
pubmed:volume
37
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1850-5
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:8239595-Amoxicillin, pubmed-meshheading:8239595-Amoxicillin-Potassium Clavulanate Combination, pubmed-meshheading:8239595-Anti-Bacterial Agents, pubmed-meshheading:8239595-Cephalosporins, pubmed-meshheading:8239595-Clavulanic Acids, pubmed-meshheading:8239595-Drug Resistance, Microbial, pubmed-meshheading:8239595-Drug Synergism, pubmed-meshheading:8239595-Drug Therapy, Combination, pubmed-meshheading:8239595-Enzyme Induction, pubmed-meshheading:8239595-Humans, pubmed-meshheading:8239595-Isoelectric Focusing, pubmed-meshheading:8239595-Microbial Sensitivity Tests, pubmed-meshheading:8239595-Nocardia, pubmed-meshheading:8239595-Nocardia Infections, pubmed-meshheading:8239595-Penicillins, pubmed-meshheading:8239595-Substrate Specificity, pubmed-meshheading:8239595-beta-Lactamases
pubmed:year
1993
pubmed:articleTitle
Partial characterization of Nocardia farcinica beta-lactamases.
pubmed:affiliation
Department of Microbiology, University of Texas Health Center at Tyler 75710.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't